Free Trial
LON:CLIN

Clinigen Group (CLIN) Share Price, News & Analysis

Clinigen Group logo

About Clinigen Group Stock (LON:CLIN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
925
925
52-Week Range
N/A
Volume
539,375 shs
Average Volume
1.83 million shs
Market Capitalization
£1.23 billion
P/E Ratio
64.69
Dividend Yield
0.82%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clinigen Group and its competitors with MarketBeat's FREE daily newsletter.

CLIN Stock News Headlines

Clinigence Holdings (NUTX) Receives a Buy from Maxim Group
Evotec Shares Jump After Triton Acquires Stake
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Triton Weighs Takeover Deal for Drug Developer Evotec
See More Headlines

CLIN Stock Analysis - Frequently Asked Questions

Clinigen Group plc (LON:CLIN) announced its quarterly earnings data on Thursday, September, 17th. The company reported $65.60 EPS for the quarter, beating analysts' consensus estimates of $63.50 by $2.10.

Shares of CLIN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Albemarle (ALB), Advanced Accelerator Applications (AAAP), First Hawaiian (FHB), GE Aerospace (GE) and Landec (LNDC).

Company Calendar

Last Earnings
9/17/2020
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Delivery
Sub-Industry
Trading
Current Symbol
LON:CLIN
CIK
N/A
Fax
N/A
Employees
1,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
64.69
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£565.60 million
Price / Cash Flow
10.48
Book Value
GBX 341.90 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£1.23 billion
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (LON:CLIN) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners